A detailed investigation on conformation, permeability and PK properties of two related cyclohexapeptides

International Journal of Peptide Research and Therapeutics

Volumn 21, Issue 2, 2015, Pages 205-221

  Lewis, Ian ^a   Schaefer, Michael ^a   Wagner, Trixie ^a   Oberer, Lukas ^a   Sager, Emine ^a   Wipfli, Peter ^a   Vorherr, Thomas ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Conformation; Cyclohexapeptides; Permeability; Pharmacokinetics

Indexed keywords

EID: 84934941380     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-014-9447-3     Document Type: Article

References (42)

1. Alex A, Millan DS, Perez M, Wakenhut F, Whitlock GA (2011) Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space. Med Chem Commun 2:669-674
2. Bockus AT, McEwen CM, Lokey RS (2013) Form and function in cyclic peptide natural products: a pharmacokinetic perspective. Curr Top Med Chem 13:821-836
3. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4:87-217
4. Calimet N, Schaefer M, Simonson T (2001) Protein molecular dynamics with the generalized born/ACESolvent model. Proteins: structure. Funct Genet 45:144-158
5. Chan WC, White PD (2000) Fmoc solid phase peptide synthesis, the practical approach series. In: Hames BD (ed), Oxford University Press, Oxford
6. Chatterjee J, Gilon C, Hoffman A, Kessler H (2008) N-methylation of peptides: a new perspective in medicinal chemistry. Acc Chem Res 41(10):1331-1342
7. Clark DE (1999) Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena, 1. Prediction of intestinal absorption. J Pharm Sci 88(8):807-814
8. Connolly ML (1983) Solvent-accessible surfaces of proteins and nucleic acids. Science 221(4612):709-713
9. Daura X, Gademann K, Jaun B, Seebach D, van Gunsteren WF, Mark AE (1999) Peptide folding: when simulation meets experiment. Angew Chem Int Ed 38:236-240
10. Deshmukh DD, Nagilla R, Ravis WR, Betageri GV (2010) Effect of dodecylmaltoside (DDM) on uptake of BCS III compounds, tiludronate and cromolyn, in Caco-2 cells and rat intestine model. Drug Deliv 17(3):145-151
11. Di L, Artursson P, Avdeef A, Ecker GF, Faller B, Fischer H, Houston JB, Kansy M, Kerns EH, Kramer SD, Lennernäs H, Kiyohiko S (2012) Evidence-based approach to assess passive diffusion and carrier-mediated drug transport. Drug Discov Today 17(15-16):905-912
12. El Tayar N, Mark AE, Vallat P, Brunne RM, Testa B, van Gunsteren WF (1993) Solvent-dependent conformation and hydrogen bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations. J Med Chem 36:3757-3764
13. Giordanetto F, Kihlberg J (2014) Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? J Med Chem 57:278-295
14. Goetz GH, Farrell W, Shalaeva M, Sciabola S, Anderson D, Yan J, Philippe L, Shapiro MJ (2014a) High throughput method for the indirect detection of intramolecular hydrogen bonding. J Med Chem 57(7):2920-2929
15. Goetz GH, Philippe L, Shapiro MJ (2014b) EPSA: A novel supercritical fluid chromatography technique enabling the design of permeable cyclic peptides. ACS Med Chem Lett. doi: 10.1021/ml500239m
16. Golor G, Hu K, Ruffin M, Buchelt A, Bouillaud E, Wang Y, Maldonado M (2012) A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers. Drug Des, Dev Therapy 6:71-79
17. Hill TA, Lohman R, Hoang HN, Nielsen DS, Scully CCG, Kok WM, Liu L, Lucke AJ, Stoermer MJ, Schroeder CI, Chaousis S, Colless B, Bernhardt PV, Edmonds DJ, Griffith DA, Rotter CJ, Ruggeri RB, Price DA, Liras S, Craik DJ, Fairlie DP (2014) Cyclic penta- and hexaleucine peptides without N-methylation are orally absorbed. ACS Med Chem Lett. doi: 10.1021/ml5002823
18. Hoveyda HR, Marsault E, Gagnon R, Mathieu AP, Vézina M, Landry A, Wang Z, Benakli K, Beaubien S, Saint-Louis C, Brassard M, Pinault J, Ouellet L, Bhat S, Ramaseshan M, Peng X, Foucher L, Beauchemin S, Bhérer P, Veber DF, Peterson ML, Fraser GL (2011) Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): development of Ulimorelin (TZP-101) from hit to clinic. J Med Chem 54:8305-8320
19. Hutchinson EG, Thornton JM (1994) A revised set of potentials for beta-turn formation in proteins. Protein Sci 3(12):2207-2216
20. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22(12):2577-2637
21. Karplus M (1959) Contact electron-spin coupling of nuclear magnetic moments. J Chem Phys 30(1):11-15
22. Kenichiro I, Passioura T, Suga H (2013) Technologies for the synthesis of mRNA-encoding libraries and discovery of bioactive natural product-inspired non-traditional macrocyclic peptides. Molecules 18:3502-3528
23. Knipp GT, Vander Velde GD, Siahaan TJ, Borchardt RT (1997) The effect of β-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers. Pharm Res 14:1332-1340
24. Liu X, Wright M, Hop CECA (2014) Rational use of plasma protein and tissue binding data in drug design. Miniperspective. J Med Chem 57(20):8238-8248
25. Ma P, Wang Y, Van Der Hoek J, Nedelman J, Schran H, Tran LL, Lamberts SW (2005) Pharmacokinetic-pharmacodynamic comparison of a novel multi ligand somatostatin analog, SOM230, with octreotide in patients with acromegaly. Clin Pharmacol Ther 78(1):69-80
26. Marzinzik AL, Vorherr Th (2013) Towards intracellular delivery of peptides. Chimia 67(12):899-905
27. Miranda E, Nordgren IK, Male AL, Lawrence CE, Hoakwie F, Cuda F, Court W, Fox KR, Townsend PA, Packham GK, Eccles SA, Tavassoli A (2013) A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. J Am Chem Soc 135(28):10418-10425
28. Mönkärea J, Hakalab RA, Kovalainena M, Korhonenb H, Herzigc K, Seppäläb JV, Järvinena K (2012) Photocrosslinked poly(ester anhydride)s for peptide delivery: effect of oligomer hydrophobicity on PYY3-36 delivery. Eur J Pharm Biopharm 80(1):33-38
29. Nielsen DS, Hoang HN, Lohman R, Diness F, Fairlie DP (2012) Total synthesis, structure, and oral absorption of a thiazole cyclic peptide, sanguinamide A. Org Lett 14(22):5720-5723
30. Okumu FW, Pauletti GM, Vander Velde GD, Siahaan TJ, Borchardt RT (1997) Effect of restricted conformational flexibility on the permeation of model hexapeptides across Caco-2 cell monolayers. Pharm Res 14:169-175
31. Over B, McCarren P, Artursson P, Foley M, Giordanetto F, Grönberg G, Hilgendorf C, Lee MD, Matsson P, Muncipinto G, Pellisson M, Perry MWD, Svensson R, Duvall JR, Kihlberg J (2014) Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical properties. J Med Chem 57:2746-2754
32. Poillot C, Bichraoui H, Tisseyre C, Bahemberae E, Andreotti N, Sabatier J, Ronjat M, De Waard M (2012) Small efficient cell-penetrating peptides derived from scorpion toxin maurocalcine. J Biol Chem 287(21):17331-17342
33. Rafi SB, Hearn BR, Vedantham P, Jacobson MP, Renslo AR (2012) Predicting and improving the membrane permeability of peptidic small molecules. J Med Chem 55(7):3163-3169
34. Ramachandran GN, Ramakrishnan C, Sasisekharan V (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol 7(1):95-99
35. Rand AC, Leung SSF, Eng H, Rotter CJ, Sharma R, Kalgutkar AS, Zhang Y, Varma MV, Farley KA, Khunte B, Limberakis C, Price DA, Liras S, Mathiowetz AM, Jacobson MP, Lokey RS (2012) Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance. Med Chem Comm 3(10):1282-1289
36. Rezai T, Bock JE, Zhou MV, Kalyanaraman C, Lokey RS, Jacobson MP (2006) Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. J Am Chem Soc 128:14073-14080
37. Rezai T, Bock JE, Zhou MV, Kalyanaraman C, Lokey RS, Jacobson MP (2011) On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. Nat Chem Biol 7:810
38. Richmond TJ (1984) Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. J Mol Biol 178(1):63-89
39. Schaefer M, Karplus M (1996) A comprehensive analytical treatment of continuum electrostatics. J Phys Chem B 100:1578-1599
40. Schaefer M, Bartels C, Karplus M (1998) Solution conformations and thermodynamics of structured peptides: molecular dynamics simulation with an implicit solvation model. J Mol Biol 284(3):835-848
41. Seidler J, McGovern SL, Doman TN, Shoichet BK (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 46:4477-4486
42. Smith D, Artursson P, Avdeef A, Di L, Ecker GF, Faller B, Houston JB, Kansy M, Kerns EH, Kramer SD, Lennernäs H, van de Waterbeemd H, Sugano K, Testa B (2014) Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition. Mol Pharm 11(6):1727-1738